Cleared Special

QUICKVUE INFLUENZA A+B

K131619 · Quidel Corp. · Microbiology
Jun 2013
Decision
25d
Days
Class 1
Risk

About This 510(k) Submission

K131619 is an FDA 510(k) clearance for the QUICKVUE INFLUENZA A+B, a Antigens, Cf (including Cf Control), Influenza Virus A, B, C (Class I — General Controls, product code GNX), submitted by Quidel Corp. (San Diego, US). The FDA issued a Cleared decision on June 28, 2013, 25 days after receiving the submission on June 3, 2013. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3330.

Submission Details

510(k) Number K131619 FDA.gov
FDA Decision Cleared SESE
Date Received June 03, 2013
Decision Date June 28, 2013
Days to Decision 25 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code GNX — Antigens, Cf (including Cf Control), Influenza Virus A, B, C
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3330

Similar Devices — GNX Antigens, Cf (including Cf Control), Influenza Virus A, B, C

All 17
ALERE BINAXNOW INFLUENZA A & B CARD
K133411 · Alere Scarborough, Inc D/B/A Binax, Inc. · Dec 2013
SAS FLUALERT A & B, SAS INFLUENZA A TEST
K132352 · Sa Scientific , Ltd. · Aug 2013
REMEL XPECT FLU A&B
K131804 · Remel, Inc. · Jul 2013
QUICK VUE INFLUENZA
K131599 · Quidel Corporation · Jul 2013
SOFIA INFLUENZA A+B FIA
K131606 · Quidel Corp. · Jul 2013
OSOM INFLUENZA A&B TEST MODEL 190
K123182 · SEKISUI Diagnostics, LLC · Nov 2012